A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Medical Writer 1

read more

Mylan ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world’s largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies.

Post: Plant Head

read more

Plant parasitic nematodes cause global crop losses of $125 billion. Current chemicals to control these pests have been withdrawn from use due to unacceptable environmental toxicity. This project will develop new experimental tools and explore new chemical agents that can be used to address this important and challenging problem. It builds on the established expertise of the academic supervisors Profs Holden-Dye and O’Connor in nematode neurobiology and involves a new collaboration with Bayer CropScience (Dr. U.

read more

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

read more

About Authors:
Bhuvanesh Sharma¹*, Bhupendra Vyas¹, Yuvraj Singh Sarangdevot¹, Pankaj Sharma¹, Abhishek Sharma¹.
¹Dept. of Quality Assurance, B.N. College of Pharmacy,
Udaipur (Raj) 313001
*bhuvan110@gmail.com

Abstract:-
A simple, specific, accurate stability indicating RP-HPLC method was developed for assay of Salmeterol xinafoate and Fluticasone propionate in Mdi using Inertsil  C-8 (150 x 4.6 mm), 5 µm Column and a mobile phase composing of Buffer: Acetonitrile: Methanol (450:250:300) v/v. The flow rate was 2.0 ml/min and the effluent was monitored at 220 nm. The retention time was 3.2 ±0.1 min and 9.9±0.1 min. Drug was subjected to acidic, alkali, oxidation degradation. The degradation studies indicated the susceptibility of drugs to various degradations. The method was statistically validated for specificity, accuracy, precision, linearity, robustness and solution stability. Quantitative and recovery studies of the dosage form were also carried out and the % RSD was found to be less than 2. The developed method is simple, rapid and accurate and hence can be used for routine quality control analysis.

read more

read more